It recommends using isoflurane and sevoflurane instead of halothane as inhalation anaesthetics in all public and private hospitals nationwide
"These results are great news as they show the remarkable efficacy of the vaccine in a new population and are consistent with the results from Oxford-led trials," Andrew Pollard, who runs the Oxford Vaccine Group, said.